Subsidiary, INGRASYS (SINGAPORE) obtaining Shares
Summary by AI BETAClose X
Subject: Subsidiary, INGRASYS (SINGAPORE) PTE. LTD. obtaining Shares
Contents:
1.Name and nature of the underlying assets (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g., dividend yield, etc.):FULIAN PRECISION TECHNOLOGY COMPONENT COMPANY LIMITED Shares
2.Date of occurrence of the event:2025/09/05
3.Date of the board of directors resolution:2025/09/05
4.Other approval date:NA
5.Amount, unit price, and total monetary amount of the transaction:
Total transaction amount:USD 39,400,000
6.Trading counterparty and its relationship with the Company (if the trading counterparty is a natural person and furthermore is not a related party of the Company, the name of the trading counterparty is not required to be disclosed):Cash investment is not applied; Parent and subsidiary companies
7.Where the trading counterparty is a related party, announcement shall also be made of the reason for choosing the related party as trading counterparty and the identity of the previous owner, its relationship with the Company and the trading counterparty, and the previous date and monetary amount of transfer:Na
8.Where an owner of the underlying assets within the past five years has been a related party of the Company, the announcement shall also include the date and price of acquisition and disposal by the related party, and its relationship with the Company at the time of the transaction:NA
9.Matters related to the current disposal of creditors' rights (including types of collaterals of the disposed creditor's rights; if creditor's rights over a related party, announcement shall be made of the name of the related party and the book amount of the creditor's rights, currently being disposed of, over such related party):NA
10.Profit or loss from the disposal (not applicable in cases of acquisition of securities) (those with deferral should provide a table explaining recognition):NA
11.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important terms and conditions:None
12.The manner of deciding on this transaction (such as invitation to tender, price comparison, or price negotiation), the reference basis for the decision on price, and the decision-making unit:Board of director
13.Net worth per share of the Company's underlying securities acquired or disposed of:NA
14.Cumulative no.of shares held (including the current transaction), their monetary amount, shareholding percentage, and status of any restriction of rights (e.g., pledges), as of the present moment:
Cumulative monetary amount held: USD 364,461,000
Shareholding percentage:100%
Restriction of rights: None
15.Current ratio of securities investment (including the current trade, as listed in article 3 of Regulations Governing the Acquisition and Disposal of Assets by Public Companies) to the total assets and equity attributable to owners of the parent as shown in the most recent financial statement and working capital as shown in the most recent financial statement as of the present:
Ratio to total assets:0.30%;
Ratio to owners'equity:0.75%;
Operating Capital:NTD-252,428,890,000
16.Broker and broker's fee:None
17.Concrete purpose or use of the acquisition or disposal:Long Term Investment
18.Any dissenting opinions of directors to the present transaction:None
19.Whether the counterparty of the current transaction is a related party:Yes
20.Date of ratification by supervisors or approval by the Audit Committee:NA
21.Whether the CPA issued an unreasonable opinion regarding the current transaction:NA
22.Name of the CPA firm:NA
23.Name of the CPA:NA
24.Practice certificate number of the CPA:NA
25.Whether the transaction involved in change of business model:No
26.Details on change of business model:NA
27.Details on transactions with the counterparty for the past year and the expected coming year:NA
28.Source of funds:private capital
29.Date on which material information regarding the same event has been previously released:NA
30.Any other matters that need to be specified:None
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 28 minutes ago Avon Technologies plc
- 1 hour ago TBC Bank Group
- 1 hour ago Moneysupermarket.com Group
- 1 hour ago Dr. Martens
- 2 hours ago Neuberger Private Equity Partners Limited